Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized dexmedetomidine to prevent postoperative sore throat after thyroid day-surgery
ChiCTR2500104635Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in Post-extubation sore throat (POST), postoperative nausea and vomiting (PONV), dysphonia, sponsored by First Affiliated Hospital of Anhui Medical University. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-extubation sore throat (POST)postoperative nausea and vomiting (PONV)dysphonia
Beyond the preview
Go deeper on ChiCTR2500104635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104635.